PDXK and Duchenne muscular dystrophy: The creation of patient-derived DT-DEC01 products through the PEG-mediated fusion of PKH single-stained myoblasts from a healthy donor (MBN) and DMD patient (MBDMD), as well as the mechanisms involved in DMD following systemic-intraosseous administration of the DT-DEC01 product, are summarized in Figure 1.